PPBT – purple biotech ltd. - american depositary shares (US:NASDAQ)

News

Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform
Yahoo Finance [Yahoo! Finance]
Purple Biotech Regains Compliance with Nasdaq
Purple Biotech (PPBT) was downgraded by Zacks Research from "hold" to "strong sell".
Purple Biotech (PPBT) had its price target lowered by HC Wainwright from $34.00 to $30.00. They now have a "buy" rating on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com